U.S. FDA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
U.S. FDA
Jul 21, 2024, 13:57 |
Blog
Herbert Loong: Regulatory processes for novel oncology therapeutics and cellular therapies at APODDC forum
Herbert Loong shared a post on X: ''We welcomed Ke Liu, former Chief of Oncology…
Jul 9, 2024, 07:52 |
Insight
Kimryn Rathmell: Big announcement from FDA regarding diversity in clinical trials
Kimryn Rathmell shared on X: “Big announcement from FDA regarding diversity in clinical trials. U.S. FDA…
Jun 28, 2024, 02:39 |
Blog
FDA guidance provides new details on diversity action plans required for certain studies
U.S. FDA shared a post on X: “Today, Food and Drug Administration issued a draft…
Jun 20, 2024, 16:06 |
Blog
Oncology community on Juneteenth
Juneteenth, also known as Freedom Day or Emancipation Day, commemorates the emancipation of enslaved African…
Jun 18, 2024, 09:57 |
Insight
Top 5 articles of the week - Cancer Network
Cancer Network shared on X/Twitter: "View our top 5 articles of the week: T-DXd Boosts…
Jun 10, 2024, 10:02 |
Insight
Udhayvir Grewal: Real world post-marketing pharmacovigilance analysis on hematological toxicities in the US
Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport, recently shared a post on X:…
May 24, 2024, 01:21 |
Insight
Recent FDA Committee Vote Could Speed Multiple Myeloma Drug Approval
Sylvester-led analysis on minimal residual disease as clinical endpoint guided committee decision A U.S. Food…
May 15, 2024, 12:01 |
Blog
David Steensma: IND application for first type II JAK2 inhibitor to go into clinical trials
David Steensma, Chief Medical Officer at Ajax Therapeutics, shared a post by Ajax Therapeutics on X/Twitter:…
May 1, 2024, 10:50 |
Blog
Chris Boshoff: The U.S. FDA granted full approval for our therapy developed with our partner Genmab
Chris Boshoff shared a post on LinkedIn: "Today, the U.S. FDA granted full approval for our…
Apr 26, 2024, 10:07 |
Drugs
Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: ''HOT OFF…
Apr 24, 2024, 17:24 |
Blog
U.S. FDA approved the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma - Day One Biopharmaceuticals
Day One Biopharmaceuticals shared a post on LinkedIn: "Breaking News: Today, we are thrilled to share…
Apr 23, 2024, 10:44 |
Blog
Ben Solomon: A timely discussion with Narjust Florez about the ALINA trial
Ben Solomon, Lung Cancer Medical Oncologist at Peter MacCallum Cancer Centre, shared a post by…
Mar 19, 2024, 03:44 |
Drugs
Nitin Jain: The U.S. FDA approves lisocabtagene maraleucel for adults with relapsed or refractory CLL or SLL
Nitin Jain, The Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Feb 8, 2024, 17:51 |
Blog
Carla Johnson: Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable
Carla Johnson, Journalist and Medical Writer at the Associated Press, shared on X/Twitter: "Cancer patients…
Jan 18, 2024, 15:16 |
Blog
Robert Califf: A conversation with Lisa Dwyer about the U.S. FDA’s role in digital health
Robert Califf, Commissioner at US Food and Drug Administration, recently posted on X/Twitter: "Appreciated the…
Jan 17, 2024, 19:34 |
Drugs
Yüksel Ürün: The U.S. FDA has approved pembrolizumab in combination with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer
Yüksel Ürün, Professor at the Department of Medical Oncology at the Ankara University School of…
Dec 29, 2023, 05:18 |
Blog
U.S. FDA summarizes their decision to restrict the approval of olaparib + abiraterone - American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO) shared on their X/Twitter page: ''Breaking from Journal of…
Dec 21, 2023, 16:21 |
Blog
Robert Califf: Moving our proposal forward is an exciting milestone in our ongoing modernization initiative
Robert Califf, Commissioner at US Food and Drug Administration, shared a post by U.S. FDA…
Jun 21, 2023, 18:41 |
Drugs
So pleased (& a little proud) to see U.S. FDA approval of Enzalutamide & Talazoparib in HRR-deficient 1L mCRPC
In a post by Arun Azad on Twitter, it says, "So pleased (& a little…
All:
19
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube